The excitatory amino acid transporters (EAATs) play essential
roles
in regulating the synaptic concentration of the neurotransmitter glutamate
in the mammalian central nervous system. To date, five subtypes have
been identified, named EAAT1–5 in humans, and GLAST, GLT-1,
EAAC1, EAAT4, and EAAT5 in rodents, respectively. In this paper, we
present the design, synthesis, and pharmacological evaluation of seven
7-N-substituted analogues of UCPH-101/102. Analogue 9 inhibited EAAT1 in the micromolar range (IC50 value 20 μM), whereas analogues 8 and 10 were inactive (IC50 values >100 μM). The diastereomeric
pairs 11a/11b and 12a/12b were separated by HPLC and the absolute configuration
assigned by VCD technique in combination with ab initio Hartree–Fock
calculations. Analogues 11a (RS-isomer)
and 12b (RR-isomer) inhibited EAAT1
(IC50 values 5.5 and 3.8 μM, respectively), whereas
analogues 11b (SS-isomer) and 12a (SR-isomer) failed to inhibit EAAT1 uptake
(IC50 values >300 μM).